DÉRIVÉS PYRIDIN-2-YL-AMINO-1,2,4-THIADIAZOLE EN TANT QU'ACTIVATEURS DE LA GLUCOKINASE POUR LE TRAITEMENT DE LA DIABÈTE SUCRÉ

• 收藏
• 分享

专利权人:

Array Biopharma; Inc.

发明人:

申请号：

EP16160414.5

公开号：

EP3078662A1

申请日:

2008.09.15

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

Provided are compounds of Formula Iwherein R2, R3, R13 , L and D2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/